These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37869975)

  • 41. Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials.
    Kelley GA; Kelley KS; Kohrt WM
    BMC Musculoskelet Disord; 2012 Sep; 13():177. PubMed ID: 22992273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
    Huang S; Lin H; Zhu X; Chen X; Fan L; Liu C
    Endokrynol Pol; 2014; 65(2):96-104. PubMed ID: 24802732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the bone sparing effects of postbiotics in the post-menopausal rat model.
    Montazeri-Najafabady N; Ghasemi Y; Dabbaghmanesh MH; Ashoori Y; Talezadeh P; Koohpeyma F; Abootalebi SN; Gholami A
    BMC Complement Med Ther; 2021 May; 21(1):155. PubMed ID: 34049521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis.
    Hong P; Liu R; Rai S; Liu J; Zhou Y; Zheng Y; Li J
    J Orthop Surg Res; 2023 Feb; 18(1):116. PubMed ID: 36797767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blosozumab in the treatment of postmenopausal women with osteoporosis: a systematic review and meta-analysis.
    Su Y; Wang W; Liu F; Cai Y; Li N; Li H; Li G; Ma L
    Ann Palliat Med; 2022 Oct; 11(10):3203-3212. PubMed ID: 36367007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis.
    Abdelazim IA; Abdelrazak KM; Al-Kadi M; Yehia AH; Nusair BM; Faza MA
    Arch Osteoporos; 2014; 9():189. PubMed ID: 25037077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychosocial stress and bone loss among postmenopausal women: results from the Women's Health Initiative.
    Follis SL; Bea J; Klimentidis Y; Hu C; Crandall CJ; Garcia DO; Shadyab AH; Nassir R; Chen Z
    J Epidemiol Community Health; 2019 Sep; 73(9):888-892. PubMed ID: 31289118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropeptide Y1 Receptor Antagonist Alters Gut Microbiota and Alleviates the Ovariectomy-Induced Osteoporosis in Rats.
    Xie W; Han Y; Li F; Gu X; Su D; Yu W; Li Z; Xiao J
    Calcif Tissue Int; 2020 Apr; 106(4):444-454. PubMed ID: 31844916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
    Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.
    Cranney A; Wells G; Willan A; Griffith L; Zytaruk N; Robinson V; Black D; Adachi J; Shea B; Tugwell P; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):508-16. PubMed ID: 12202465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis.
    Gao S; Zhao Y
    Qual Life Res; 2023 Jun; 32(6):1551-1565. PubMed ID: 36383282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of dynamic resistance exercise on bone mineral density in postmenopausal women: a systematic review and meta-analysis with special emphasis on exercise parameters.
    Shojaa M; von Stengel S; Kohl M; Schoene D; Kemmler W
    Osteoporos Int; 2020 Aug; 31(8):1427-1444. PubMed ID: 32399891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of APOE Gene in Bone Mineral Density and Incidence of Bone Fractures in Brazilian Postmenopausal Women.
    Souza LS; Rochette NF; Pedrosa DF; Magnago RPL; Filho TBF; Vieira FLH; Fin IDCF; Eis SR; Graceli JB; Rangel LBA; Silva IV
    J Clin Densitom; 2018; 21(2):227-235. PubMed ID: 28784276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kefir improves bone mass and microarchitecture in an ovariectomized rat model of postmenopausal osteoporosis.
    Chen HL; Tung YT; Chuang CH; Tu MY; Tsai TC; Chang SY; Chen CM
    Osteoporos Int; 2015 Feb; 26(2):589-99. PubMed ID: 25278298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis.
    Zhao R; Zhao M; Xu Z
    Osteoporos Int; 2015 May; 26(5):1605-18. PubMed ID: 25603795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TBS in early postmenopausal women with severe vertebral osteoporosis.
    Pouillès JM; Gosset A; Breteau A; Trémollieres FA
    Bone; 2021 Jan; 142():115698. PubMed ID: 33091641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.